“Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.
Pharmaceutical companies and their development partners are continually looking for safe, efficient ways to accelerate delivery of therapies to the patients that need them—especially in the face of the COVID-19 pandemic. One appealing path to new treatments is to explore ways to repurpose a drug intended for one indication and repurpose it for another…”
Read the full article where Editor for Outsourcing Pharma, Jenni Spinner, interviews SEKISUI XenoTech Director of Consulting, Dr. Maciej Czerwinski, about preclinical challenges associated with repurposing drugs as a follow up to key points discussed in our recent blog post, “Important DDI Considerations for Repurposing Drugs to Treat COVID-19.”
Learn more about:
About the Authors
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback